Encinas Danielle, Plante Elena
Lang Speech Hear Serv Sch. 2016 Apr 1;47(2):157-70. doi: 10.1044/2016_LSHSS-15-0060.
There is little to guide clinicians in terms of evidence-based interventions for children with cochlear implants who demonstrate morpheme errors. This feasibility study tested the utility of a treatment targeting grammatical morpheme errors.
Three children (ages 4-5 years) received Enhanced Conversational Recast treatment, a version of conversational recast treatment that focuses on a single morpheme error at a time, emphasizes attention to clinician input, and uses high linguistic variability with clinician input. A period of recasting was followed by 24 auditory presentations of the target morpheme in short sentences. After an initial baseline period, children were treated in individual sessions over 21-26 days.
All children showed improved use of targeted grammatical morpheme use, both in elicited contexts and in terms of spontaneous use. Spontaneous use was best for the 2 children who were implanted earliest and whose audiograms showed the best hearing postimplant. Performance by a 3rd child diagnosed with auditory neuropathy spectrum disorder was more variable but still showed positive change.
The results indicate that the treatment can be effective for children with cochlear implants. The pattern of results across children also suggests potential variables that may moderate treatment effects.
对于表现出词素错误的人工耳蜗植入儿童,几乎没有基于证据的干预措施可供临床医生参考。本可行性研究测试了一种针对语法词素错误的治疗方法的效用。
三名儿童(4 - 5岁)接受了强化对话重铸治疗,这是一种对话重铸治疗方法,一次专注于一个词素错误,强调对临床医生输入的关注,并在临床医生输入时使用高语言变异性。一段重铸期之后是在短句子中对目标词素进行24次听觉呈现。在初始基线期之后,儿童在21 - 26天内接受个别治疗。
所有儿童在诱发情境和自发使用方面,目标语法词素的使用都有改善。自发使用情况对于最早植入且植入后听力图显示听力最佳的两名儿童最为理想。第三名被诊断为听觉神经病谱系障碍的儿童的表现更具变异性,但仍显示出积极变化。
结果表明该治疗方法对人工耳蜗植入儿童可能有效。不同儿童的结果模式也表明了可能影响治疗效果的潜在变量。